These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 24983891)
21. Head and neck cancer radiosensitization by the novel poly(ADP-ribose) polymerase inhibitor GPI-15427. Khan K; Araki K; Wang D; Li G; Li X; Zhang J; Xu W; Hoover RK; Lauter S; O'Malley B; Lapidus RG; Li D Head Neck; 2010 Mar; 32(3):381-91. PubMed ID: 19672867 [TBL] [Abstract][Full Text] [Related]
23. Retinoblastoma RB94 enhances radiation treatment of head and neck squamous cell carcinoma. Araki K; Ahmad SM; Li G; Bray DA; Saito K; Wang D; Wirtz U; Sreedharan S; O'Malley BW; Li D Clin Cancer Res; 2008 Jun; 14(11):3514-9. PubMed ID: 18519784 [TBL] [Abstract][Full Text] [Related]
24. Combined radiation sensitizing and anti-angiogenic effects of ionizing radiation and the protease inhibitor ritonavir in a head and neck carcinoma model. Maggiorella L; Wen B; Frascogna V; Opolon P; Bourhis J; Deutsch E Anticancer Res; 2005; 25(6B):4357-62. PubMed ID: 16309240 [TBL] [Abstract][Full Text] [Related]
25. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Leonard CE; Chan DC; Chou TC; Kumar R; Bunn PA Cancer Res; 1996 Nov; 56(22):5198-204. PubMed ID: 8912857 [TBL] [Abstract][Full Text] [Related]
26. Different mechanisms of cell death in radiosensitive and radioresistant p53 mutated head and neck squamous cell carcinoma cell lines exposed to carbon ions and x-rays. Maalouf M; Alphonse G; Colliaux A; Beuve M; Trajkovic-Bodennec S; Battiston-Montagne P; Testard I; Chapet O; Bajard M; Taucher-Scholz G; Fournier C; Rodriguez-Lafrasse C Int J Radiat Oncol Biol Phys; 2009 May; 74(1):200-9. PubMed ID: 19362238 [TBL] [Abstract][Full Text] [Related]
27. The effect of red-allotrope selenium nanoparticles on head and neck squamous cell viability and growth. Hassan CE; Webster TJ Int J Nanomedicine; 2016; 11():3641-54. PubMed ID: 27536104 [TBL] [Abstract][Full Text] [Related]
28. Anti-tumor effects of bevacizumab in combination with paclitaxel on head and neck squamous cell carcinoma. Fujita K; Sano D; Kimura M; Yamashita Y; Kawakami M; Ishiguro Y; Nishimura G; Matsuda H; Tsukuda M Oncol Rep; 2007 Jul; 18(1):47-51. PubMed ID: 17549344 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533 [TBL] [Abstract][Full Text] [Related]
30. Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model. Lin LT; Chang CY; Chang CH; Wang HE; Chiou SH; Liu RS; Lee TW; Lee YJ Oncotarget; 2016 Oct; 7(40):65782-65796. PubMed ID: 27588466 [TBL] [Abstract][Full Text] [Related]
31. Combination antiangiogenic therapy and radiation in head and neck cancers. Hsu HW; Wall NR; Hsueh CT; Kim S; Ferris RL; Chen CS; Mirshahidi S Oral Oncol; 2014 Jan; 50(1):19-26. PubMed ID: 24269532 [TBL] [Abstract][Full Text] [Related]
32. Radiosensitization Effect of AGuIX, a Gadolinium-Based Nanoparticle, in Nonsmall Cell Lung Cancer. Du Y; Sun H; Lux F; Xie Y; Du L; Xu C; Zhang H; He N; Wang J; Liu Y; Leduc G; Doussineau T; Ji K; Wang Q; Lin Z; Wang Y; Liu Q; Tillement O ACS Appl Mater Interfaces; 2020 Dec; 12(51):56874-56885. PubMed ID: 33326207 [TBL] [Abstract][Full Text] [Related]
33. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy. Riedel F; Götte K; Hörmann K; Grandis JR Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422 [TBL] [Abstract][Full Text] [Related]
34. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma. Scher RL Laryngoscope; 2007 Feb; 117(2):199-209. PubMed ID: 17277613 [TBL] [Abstract][Full Text] [Related]
35. Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice. Zou J; Qiao X; Ye H; Yang Y; Zheng X; Zhao H; Liu S J Exp Clin Cancer Res; 2008 Oct; 27(1):56. PubMed ID: 18950535 [TBL] [Abstract][Full Text] [Related]
37. STI-571 (Gleevec) potentiates the effect of cisplatin in inhibiting the proliferation of head and neck squamous cell carcinoma in vitro. Wang-Rodriguez J; Lopez JP; Altuna X; Chu TS; Weisman RA; Ongkeko WM Laryngoscope; 2006 Aug; 116(8):1409-16. PubMed ID: 16885745 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma. Bonner JA; Yang ES; Trummell HQ; Nowsheen S; Willey CD; Raisch KP Radiother Oncol; 2011 Jun; 99(3):339-43. PubMed ID: 21704410 [TBL] [Abstract][Full Text] [Related]
39. Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma. Gyanchandani R; Sano D; Ortega Alves MV; Klein JD; Knapick BA; Oh S; Myers JN; Kim S Oral Oncol; 2013 Aug; 49(8):761-70. PubMed ID: 23623402 [TBL] [Abstract][Full Text] [Related]
40. The enhancement of tumor radioresponse by combined treatment with cepharanthine is accompanied by the inhibition of DNA damage repair and the induction of apoptosis in oral squamous cell carcinoma. Harada T; Harada K; Ueyama Y Int J Oncol; 2012 Aug; 41(2):565-72. PubMed ID: 22664937 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]